A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials

oleh: Min Yang, Wenhao Zhang, Kang Yu, Peng Wang, Hua Jiang, Linjun Chen, Haitao Meng, Yiqin Weng, Rong Tao, Xin Huang, Chongyun Xing, Huamao Wang, Jiangbo Wan, Shasha Wang, Lihui Dai, Amanda Y. Hendrix, Jun Xiao, Wei Wang, Hong Ma, Siguo Hao, Jie Jin, Zonghai Li, Songfu Jiang

Format: Article
Diterbitkan: Ferrata Storti Foundation 2022-04-01

Deskripsi

No description available for this item.